Overview:

Today the media has placed a great emphasis on practitioners and the prescribing of controlled substances. In some cases, the practitioner has been targeted and labeled as a "Pill Mill" or a "Drug Dealers" by the public stories.

Every practitioner who prescribes any drug substance that is documented as part of a treatment plan should protect themselves by knowing the federal laws and regulations imposed by the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion).

Areas Covered In the Session: Class participants, especially practitioners and their medical staff, will get a better understanding of DEA regulations pertaining to Schedules II through V drugs that are administered, dispensed, or prescribed by a practitioner as part of a treatment plan.

The presentation will:

• Identify the role and actions of DEA Diversion in enforcing federal laws and regulations for the administering, dispensing and prescribing of controlled substances as part of a treatment plan. The actions include criminal and administrative actions on practitioners who prescribe controlled substances as part of a patient treatment plan.
  
• Discuss the importance of maintaining a good patient chart that will show the diagnosis for the prescribing of controlled substances as part of a treatment plan. This includes the use of a patient agreement and the steps leading to a treatment plan.
  
• Review DEA regulations pertaining to the administering, dispensing and prescribing of controlled substance by practitioners. This includes DEA electronic prescriptions, the DEA regulation pertaining to a 90-day supply of a Schedule II drug, and other dispensing regulations.

• Compliance Managers
• Quality Managers
• DEA Professionals
• Manufacturers
• Distributers